BioMarin Pharma (BMRN) Tops Q1 EPS by 39c
Tweet
Share
E-mail
Get Alerts BMRN Hot Sheet
Price: $56.50 --0%
Revenue Growth %: +13.2%
Financial Fact:
Provision for income taxes: -24.02M
Today's EPS Names:
DTGI, CRMT, MAYS, More
Revenue Growth %: +13.2%
Financial Fact:
Provision for income taxes: -24.02M
Today's EPS Names:
DTGI, CRMT, MAYS, More
Join SI Premium – FREE
BioMarin Pharma (NASDAQ: BMRN) reported Q1 EPS of $0.60, $0.39 better than the analyst estimate of $0.21. Revenue for the quarter came in at $596.4 million versus the consensus estimate of $571.33 million.
For earnings history and earnings-related data on BioMarin Pharma (BMRN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Worthington Industries (WOR) Misses Q4 EPS by 9c
- St. James's Place plc (STJ:LN) (STJPF) PT Raised to GBP20.50 at Deutsche Bank
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
